Kindred Biosciences, Inc.

United States of America

Create a watch for Kindred Biosciences, Inc.
Total IP 33
Total IP Rank # 44,275
IP Activity Score 1.7/5.0    8
IP Activity Rank # 115,411
Stock Symbol KIN (nasdaq)
ISIN US4945771099
Market Cap. 148M  (USD)
Industry Biotechnology
Sector Healthcare
Dominant Nice Class Pharmaceutical, veterinary and s...

Patents

Trademarks

5 1
1 0
25 0
1
 
Last Patent 2025 - Variant asparaginase polypeptide...
First Patent 2013 - Vegf receptor fusion proteins fo...
Last Trademark 2019 - ZIMETA
First Trademark 2016 - KINDLET

Industry (Nice Classification)

Latest Inventions, Goods, Services

2024 Invention Variant asparaginase polypeptides for medical use. Provided are various embodiments relating to ...
2021 Invention Tnf alpha and ngf antibodies for veterinary use. Provided are various embodiments relating to can...
Invention Long-acting anti-il31 antibodies for veterinary use. Provided are various embodiments relating to...
Invention Il4/il13 receptor molecules for veterinary use. Provided are various embodiments relating to IL13...
Invention Anti-il4 receptor antibodies for veterinary use. Provided are various embodiments relating to ant...
2020 Invention Anti-il31 antibodies for veterinary use. Provided are various embodiments relating to anti-IL31 a...
Invention Parvovirus antibodies for veterinary use. Provided are various embodiments relating to parvovirus...
Invention Equine esomeprazole formulations and methods of use. The present disclosure relates to formulatio...
Invention Ngf antagonists for medical use. Provided are various embodiments relating to TrkA ECD polypeptid...
2019 Invention Igg fc variants for veterinary use. Provided are various embodiments relating to variant IgG Fc ...
Invention Igg fc variants for veterinary use. Provided are various embodiments relating to variant IgG Fc p...
Invention Erythropoietin analogs for veterinary use. Provided are various embodiments relating to erythropo...
Invention Il4/il13 receptor molecule for veterinary use. Provided are various embodiments relating to IL13R...
Invention Fc variants with altered binding to neonatal fc receptor (fcrn) for veterinary use. Provided are ...
Invention Variant asparaginase polypeptides for medical use. Provided are various embodiments relating to v...
G/S Veterinary preparations, namely, anti-inflammatory and/or antipyretic preparations
2018 Invention Anti-il31 antibodies for veterinary use. Provided are various embodiments relating to anti-IL31 ...
Invention Il17a antibodies and antagonists for veterinary use. Provided are various embodiments relating to...
Invention Erythropoietin and analogs for veterinary use. Provided are various embodiments relating to felin...
2016 G/S Veterinary preparations for the treatment of atopic dermatitis, cancer, osteoarthritis, pain, sei...
Invention Compositions and methods for treatment and prevention of pyrexia in horses. Methods for treating ...
Invention Stimulation of appetite, management of weight loss, and treatment of anorexia in dogs and cats. P...
2014 Invention Treatment of pain in animals. Pharmaceutical formulations and unit dose forms useful for the trea...
Invention Treatment of atopic dermatitis in non-human animals. Atopic dermatitis and pruritus can be effica...
2013 Invention Methods for drug delivery. Methods for delivering a drug to an animal while preventing or reduci...
Invention Vegf receptor fusion proteins for veterinary use. Companion animal vascular endothelial growth fa...